Global Coagulation Controls Market Growth 2025-2031

Publication ID:

LPI04255055

Publication Date:

April 23, 2025

Pages:

140

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Coagulation Controls market size is predicted to grow from US$ 9279 million in 2025 to US$ 13650 million in 2031; it is expected to grow at a CAGR of 6.6% from 2025 to 2031.
This product is a calibrator for prothrombin time (PT) and fibrinogen (FIB) test items.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The 鈥淐oagulation Controls Industry Forecast鈥� looks at past sales and reviews total world Coagulation Controls sales in 2024, providing a comprehensive analysis by region and market sector of projected Coagulation Controls sales for 2025 through 2031. With Coagulation Controls sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Coagulation Controls industry.
This Insight Report provides a comprehensive analysis of the global Coagulation Controls landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Coagulation Controls portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Coagulation Controls market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Coagulation Controls and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Coagulation Controls.
This report presents a comprehensive overview, market shares, and growth opportunities of Coagulation Controls market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
10 Vials/Box
12 Vials/Box
Segmentation by Application:
Hospital
Research Institute
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche
Stago
Technoclone
Sekisui Medical
Yusen Bio
King Diagnostic
Sysmex
Randox
Siemens Healthineers
Excelen
Union Bio
Wondfo Biotech
Zonci
Liangchen
Jlang
Succeeder
Key Questions Addressed in this Report
What is the 10-year outlook for the global Coagulation Controls market?
What factors are driving Coagulation Controls market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Coagulation Controls market opportunities vary by end market size?
How does Coagulation Controls break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Coagulation Controls Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Coagulation Controls by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Coagulation Controls by Country/Region, 2020, 2024 & 2031
2.2 Coagulation Controls Segment by Type
2.2.1 10 Vials/Box
2.2.2 12 Vials/Box
2.3 Coagulation Controls Sales by Type
2.3.1 Global Coagulation Controls Sales Market Share by Type (2020-2025)
2.3.2 Global Coagulation Controls Revenue and Market Share by Type (2020-2025)
2.3.3 Global Coagulation Controls Sale Price by Type (2020-2025)
2.4 Coagulation Controls Segment by Application
2.4.1 Hospital
2.4.2 Research Institute
2.4.3 Other
2.5 Coagulation Controls Sales by Application
2.5.1 Global Coagulation Controls Sale Market Share by Application (2020-2025)
2.5.2 Global Coagulation Controls Revenue and Market Share by Application (2020-2025)
2.5.3 Global Coagulation Controls Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Coagulation Controls Breakdown Data by Company
3.1.1 Global Coagulation Controls Annual Sales by Company (2020-2025)
3.1.2 Global Coagulation Controls Sales Market Share by Company (2020-2025)
3.2 Global Coagulation Controls Annual Revenue by Company (2020-2025)
3.2.1 Global Coagulation Controls Revenue by Company (2020-2025)
3.2.2 Global Coagulation Controls Revenue Market Share by Company (2020-2025)
3.3 Global Coagulation Controls Sale Price by Company
3.4 Key Manufacturers Coagulation Controls Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Coagulation Controls Product Location Distribution
3.4.2 Players Coagulation Controls Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Coagulation Controls by Geographic Region
4.1 World Historic Coagulation Controls Market Size by Geographic Region (2020-2025)
4.1.1 Global Coagulation Controls Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Coagulation Controls Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Coagulation Controls Market Size by Country/Region (2020-2025)
4.2.1 Global Coagulation Controls Annual Sales by Country/Region (2020-2025)
4.2.2 Global Coagulation Controls Annual Revenue by Country/Region (2020-2025)
4.3 Americas Coagulation Controls Sales Growth
4.4 APAC Coagulation Controls Sales Growth
4.5 Europe Coagulation Controls Sales Growth
4.6 Middle East & Africa Coagulation Controls Sales Growth
5 Americas
5.1 Americas Coagulation Controls Sales by Country
5.1.1 Americas Coagulation Controls Sales by Country (2020-2025)
5.1.2 Americas Coagulation Controls Revenue by Country (2020-2025)
5.2 Americas Coagulation Controls Sales by Type (2020-2025)
5.3 Americas Coagulation Controls Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Coagulation Controls Sales by Region
6.1.1 APAC Coagulation Controls Sales by Region (2020-2025)
6.1.2 APAC Coagulation Controls Revenue by Region (2020-2025)
6.2 APAC Coagulation Controls Sales by Type (2020-2025)
6.3 APAC Coagulation Controls Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Coagulation Controls by Country
7.1.1 Europe Coagulation Controls Sales by Country (2020-2025)
7.1.2 Europe Coagulation Controls Revenue by Country (2020-2025)
7.2 Europe Coagulation Controls Sales by Type (2020-2025)
7.3 Europe Coagulation Controls Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Coagulation Controls by Country
8.1.1 Middle East & Africa Coagulation Controls Sales by Country (2020-2025)
8.1.2 Middle East & Africa Coagulation Controls Revenue by Country (2020-2025)
8.2 Middle East & Africa Coagulation Controls Sales by Type (2020-2025)
8.3 Middle East & Africa Coagulation Controls Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Coagulation Controls
10.3 Manufacturing Process Analysis of Coagulation Controls
10.4 Industry Chain Structure of Coagulation Controls
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Coagulation Controls Distributors
11.3 Coagulation Controls Customer
12 World Forecast Review for Coagulation Controls by Geographic Region
12.1 Global Coagulation Controls Market Size Forecast by Region
12.1.1 Global Coagulation Controls Forecast by Region (2026-2031)
12.1.2 Global Coagulation Controls Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Coagulation Controls Forecast by Type (2026-2031)
12.7 Global Coagulation Controls Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Coagulation Controls Product Portfolios and Specifications
13.1.3 Roche Coagulation Controls Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Stago
13.2.1 Stago Company Information
13.2.2 Stago Coagulation Controls Product Portfolios and Specifications
13.2.3 Stago Coagulation Controls Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Stago Main Business Overview
13.2.5 Stago Latest Developments
13.3 Technoclone
13.3.1 Technoclone Company Information
13.3.2 Technoclone Coagulation Controls Product Portfolios and Specifications
13.3.3 Technoclone Coagulation Controls Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Technoclone Main Business Overview
13.3.5 Technoclone Latest Developments
13.4 Sekisui Medical
13.4.1 Sekisui Medical Company Information
13.4.2 Sekisui Medical Coagulation Controls Product Portfolios and Specifications
13.4.3 Sekisui Medical Coagulation Controls Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sekisui Medical Main Business Overview
13.4.5 Sekisui Medical Latest Developments
13.5 Yusen Bio
13.5.1 Yusen Bio Company Information
13.5.2 Yusen Bio Coagulation Controls Product Portfolios and Specifications
13.5.3 Yusen Bio Coagulation Controls Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Yusen Bio Main Business Overview
13.5.5 Yusen Bio Latest Developments
13.6 King Diagnostic
13.6.1 King Diagnostic Company Information
13.6.2 King Diagnostic Coagulation Controls Product Portfolios and Specifications
13.6.3 King Diagnostic Coagulation Controls Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 King Diagnostic Main Business Overview
13.6.5 King Diagnostic Latest Developments
13.7 Sysmex
13.7.1 Sysmex Company Information
13.7.2 Sysmex Coagulation Controls Product Portfolios and Specifications
13.7.3 Sysmex Coagulation Controls Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sysmex Main Business Overview
13.7.5 Sysmex Latest Developments
13.8 Randox
13.8.1 Randox Company Information
13.8.2 Randox Coagulation Controls Product Portfolios and Specifications
13.8.3 Randox Coagulation Controls Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Randox Main Business Overview
13.8.5 Randox Latest Developments
13.9 Siemens Healthineers
13.9.1 Siemens Healthineers Company Information
13.9.2 Siemens Healthineers Coagulation Controls Product Portfolios and Specifications
13.9.3 Siemens Healthineers Coagulation Controls Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Siemens Healthineers Main Business Overview
13.9.5 Siemens Healthineers Latest Developments
13.10 Excelen
13.10.1 Excelen Company Information
13.10.2 Excelen Coagulation Controls Product Portfolios and Specifications
13.10.3 Excelen Coagulation Controls Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Excelen Main Business Overview
13.10.5 Excelen Latest Developments
13.11 Union Bio
13.11.1 Union Bio Company Information
13.11.2 Union Bio Coagulation Controls Product Portfolios and Specifications
13.11.3 Union Bio Coagulation Controls Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Union Bio Main Business Overview
13.11.5 Union Bio Latest Developments
13.12 Wondfo Biotech
13.12.1 Wondfo Biotech Company Information
13.12.2 Wondfo Biotech Coagulation Controls Product Portfolios and Specifications
13.12.3 Wondfo Biotech Coagulation Controls Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Wondfo Biotech Main Business Overview
13.12.5 Wondfo Biotech Latest Developments
13.13 Zonci
13.13.1 Zonci Company Information
13.13.2 Zonci Coagulation Controls Product Portfolios and Specifications
13.13.3 Zonci Coagulation Controls Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Zonci Main Business Overview
13.13.5 Zonci Latest Developments
13.14 Liangchen
13.14.1 Liangchen Company Information
13.14.2 Liangchen Coagulation Controls Product Portfolios and Specifications
13.14.3 Liangchen Coagulation Controls Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Liangchen Main Business Overview
13.14.5 Liangchen Latest Developments
13.15 Jlang
13.15.1 Jlang Company Information
13.15.2 Jlang Coagulation Controls Product Portfolios and Specifications
13.15.3 Jlang Coagulation Controls Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Jlang Main Business Overview
13.15.5 Jlang Latest Developments
13.16 Succeeder
13.16.1 Succeeder Company Information
13.16.2 Succeeder Coagulation Controls Product Portfolios and Specifications
13.16.3 Succeeder Coagulation Controls Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Succeeder Main Business Overview
13.16.5 Succeeder Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂